Specialized Disclosure Report (sd)
May 30 2017 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
DarioHealth Corp.
(Exact name of registrant as specified
in its charter)
Delaware
|
|
001-37704
|
|
45-2973162
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
9 Halamish Street
Caesarea Industrial Park
3088900, Israel
(Address of principal executive offices)
(Zip Code)
Zvi Ben David, Chief Financial Officer
+972-4-770-4055
(Name and telephone number, including
area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to
which this form is being filed, and provide the period to which the information in this form applies:
☒
|
Rule 13p-1 under the Securities and Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2016.
|
Section 1 – Conflict Minerals Disclosure
Item 1.01:
|
Conflict Minerals Disclosure and Report
|
DarioHealth Corp. is a mobile health (mHealth) company that
is developing and commercializing a patented and proprietary technology providing consumers with laboratory-testing capabilities
using smart phones and other mobile devices. Our first product, Dario™, is a mobile, cloud-based, diabetes management solution
which includes novel software applications combined with a stylish, ‘all-in-one’, pocket-sized, blood glucose monitoring
device, which we call the Dario™ Smart Meter. All references to “we,” “us,” or “our”
shall mean DarioHealth Corp. and unless the context otherwise requires, its consolidated subsidiaries.
A company is required to file this Report pursuant to Rule 13p-1
promulgated under the Securities Exchange Act of 1934, as amended, if it manufactures, or contracts to manufacture, products for
which certain specified minerals are necessary to the functionality or production of the products, regardless of the geographic
origin of the minerals and whether or not they fund armed conflict. These minerals are referred to as “conflict minerals”
and consist of columbite-tantalite, cassiterite and wolframite (and their derivatives tantalum, tin, and tungsten), and gold.
We manufacture, or contract to manufacture, certain products
for which conflict minerals are necessary to the functionality or production of those products. Accordingly, we conducted in good
faith a reasonable country of origin inquiry (“RCOI”) regarding conflict minerals contained in our products manufactured
in calendar year 2016. We believe our RCOI was reasonably designed to determine whether any conflict minerals contained in those
products originated in the Democratic Republic of the Congo (DRC) or an adjoining country (together, the “Covered Countries”),
or are from recycled or scrap sources.
We first conducted a detailed review of our purchases of materials
necessary to the functionality or production of our products that we manufactured in 2016 to determine whether we purchase any
conflict minerals. We determined that certain of our products (collectively, the “covered products”) contain some conflict
minerals (namely, gold) that are necessary to the functionality or production of those products. We do not directly purchase conflict
minerals, nor do we have any direct relationship with any mines or smelters that process these minerals. In conducting our RCOI,
we conducted a supply-chain survey with our suppliers using the Electronic Industry Citizenship Coalition and Global e-Sustainability
(“EICC-GeSI”) Conflict Minerals Reporting Template. We required our direct suppliers of materials for covered products
to complete certifications concerning their manufacturing practices and the materials they supply to us. All of our suppliers of
materials for covered products manufactured in 2016 certified that the conflict minerals contained in materials supplied to us
were not sourced from Covered Countries and are from recycled or scrap sources.
As a result of our RCOI, we determined that we have no reason
to believe that the conflict minerals contained in our products originated from the Covered Countries or were not from recycled
or scrap sources.
The information contained in this section is also publicly
available on the Company’s website at www.mydario.com.
Not applicable.
Section 2 – Exhibits
Not applicable.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
DarioHealth Corp.
|
|
(Registrant)
|
|
|
|
|
By:
|
|
/s/ Zvi Ben David
|
|
|
|
(Signature)
|
|
Name:
|
|
Zvi Ben David
|
|
Title:
|
|
Chief Financial Officer, Treasurer and Secretary
|
Date: May 30, 2017
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Apr 2024 to May 2024
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From May 2023 to May 2024